The New York Office of Cannabis Management Publishes Educational Fact Sheet on Cannabis and Fentanyl
To address misinformation surrounding fentanyl and cannabis, the New York Office of Cannabis Management published a fact sheet.
In October 2023, the New York Office of Cannabis Management (OCM) published “Cannabis and Fentanyl: Facts and Unknowns,” in the Educational Materials section of their website (1,2). Legislation legalizing adult-use cannabis in the state was signed into law in March 2021 and the OCM, governed by the Cannabis Control Board, was created to regulate cannabis, including issuing licenses (2). Medical cannabis had already been legal in the state before 2021 (2).
The fact sheet defined fentanyl and explained that it is becoming increasingly common in unregulated drug supplies (1). “Warnings related to fentanyl ‘contamination’ in cannabis have increased as states continue to legalize cannabis,” the fact sheet also stated (1). “At this time, there have been zero verified incidents of fentanyl ‘contamination’ in cannabis. There is no guarantee that any unregulated cannabis product is free from contaminants or harmful ingredients.”
The purpose of the two-page sheet is to (1) “address misconceptions about cannabis being mixed with fentanyl. The goal of this fact sheet is to provide evidence where it is available, to share information about what is currently known and unknown, and to provide safety tips to help alleviate some of these misconceptions, often spread through misinformed media coverage and anecdotal reporting.” It included key findings, explained ways to reduce the stigma around opioid overdoses, and provided safety recommendations for cannabis users (1).
Some of the key findings included (2):
- Misinformation continues to be widespread about the dangers of accidentally overdosing on cannabis “contaminated” with fentanyl.
- Anecdotal accounts of cannabis “contaminated” by fentanyl have been found to be false at the time of publication.
- Reliable testing protocols for detecting fentanyl on cannabis flower are still unknown.
The OCM recommended that cannabis users buy products from licensed stores to ensure they are laboratory tested for contaminants, and cautioned that products from unregulated supplies can be untested or improperly labelled (1).
References
- Cannabis and fentanyl: Facts and unknowns https://cannabis.ny.gov/system/files/documents/2023/10/ocm_cannabisandfentanyl.pdf (accessed Nov 8, 2023).
- Marihuana regulation and taxation act (MRTA) https://cannabis.ny.gov/marihuana-regulation-and-taxation-act-mrta (accessed Nov 7, 2023).
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
